International Business Development and Activation Director.

Michael Malek is an executive, angel investor, advisor and board member with expertise in Finance, Investment, Hedge Funds, MedTech, and Value Based Healthcare. He possesses an international experience with a strong experience in Europe (UK, France, Switzerland, Belgium, Spain, Italy, Netherlands), and  MENA (North Africa, South Africa, Gulf states, and levant). In addition to his day to day activities leading go to market strategy, business development, and implementation for Diabeter Clinics across key markets internationally, negotiating with key stakeholders and governments, and supporting/overseeing implementation of similar novel care concepts under BD & Strategy at Medtronic, Michael is also a Value Based Health care subject matter expert and speaker in MEA, helping governments and institutions move towards Value Based Health care models. Michael is also a mentor and advisor to several startups in regional accelerator programs. Earlier, he was responsible for Market Access and expansion of strategic projects in collaboration with Private Equity Funds across Emerging Markets. Before joining Medtronic, Michael held several financial and consulting positions varying from Price Waterhouse Coopers in the Middle East, McKinsey & Co Spin-off in the UK, Belgium, and Switzerland and Passport Capital in the US. He also held the positions of Pricing and Market Access Strategy Director and BD and Strategy Director at Eli Lilly & Co covering South Asia, Middle East, Turkey, and Africa. Michael holds an MBA from INSEAD, and a Bachelor’s in Business Administration from the American University of Beirut (AUB, Lebanon). Michael holds additional certifications as CPA/CISA and more recently a Certificate in ‘Strategy in The Age of Digital Disruption’ at INSEAD. He currently resides in Dubai and is the proud father of two girls.